Abstract
We report a durable (12-month) response to capecitabine monotherapy, shown clinically, by MRI, and by cerebrospinal fluid analysis, in a patient with leptomeningeal metastasis from breast cancer.
Cite
CITATION STYLE
APA
Rogers, L. R., Remer, S. E., & Tejwani, S. (2004). Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy. Neuro-Oncology, 6(1), 63–64. https://doi.org/10.1215/S1152851703000334
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free